KPC: an important mechanism of resistance in K. pneumoniae isolates from intensive care units in the Midwest region of Brazil
Author(s) -
Caroline Conci Campos,
Náthalia Franco Roriz,
Camila Nogueira Espínola,
Fernando Aguilar Lopes,
Caroline Tieppo,
Andyane Freitas Tetila,
Cláudia Elizabeth VolpeChaves,
Priscilla Alexandrino de Oliveira,
Marilene Rodrigues Chang
Publication year - 2017
Publication title -
the journal of infection in developing countries
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.322
H-Index - 49
eISSN - 2036-6590
pISSN - 1972-2680
DOI - 10.3855/jidc.8920
Subject(s) - klebsiella pneumoniae , piperacillin , microbiology and biotechnology , aztreonam , ciprofloxacin , tazobactam , amikacin , antibiotic resistance , pneumonia , medicine , imipenem , antibiotics , biology , pseudomonas aeruginosa , bacteria , biochemistry , genetics , escherichia coli , gene
Infections caused by multidrug-resistant Klebsiella pneumoniae are difficult to treat and pose a serious threat to public health worldwide. Here, we describe the presence of carbapenemase-producing K. pneumoniae in intensive care units (ICU) of three major Mato Grosso do Sul hospitals located in the Midwest region of Brazil.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom